Background. Cardiovascular disease (CVD) is the leading cause of death in renal transplant
recipients with a functioning allograft. Modification of CVD risk factors may, therefore …

Abstract Introduction Despite advancements in Cytomegalovirus (CMV) management, its
impact on graft function, mortality, and cardiovascular (CV) health of organ transplant …

The survival of transplant recipients is significantly lower than age-matched controls in the
general population. The aim of this study was to analyze the trends in mortality of renal …

A number of governmental jurisdictions and public agencies have been creating their own
version of the PerformanceStat class of performance strategies. The New York City Police …

Introducción y Objetivos: A pesar del desarrollo del trasplante nuestros resultados se ven
afectados por la aparición de complicaciones médicas y quirúrgicas entorpeciendo su …

It has been shown previously that the serum level of F2-isoprostanes acts as an indicator of
oxidative stress, which is a risk factor for vascular disease especially in the end-stage renal …

INTRODUCTION: Calcineurin inhibitors (CNI) have brought dramatic improvements in early
renal allograft survival. However, CNI are associated with posttransplant hypertension …

BACKGROUND: In renal transplant recipients (RTR) an increased risk to develop
cardiovascular injury is present. Transthoracic Doppler echocardiographic assessment of …

Cardiovascular diseases (CVD) are the leading cause of mortality in renal transplant
recipients. Various traditional and unconventional cardiovascular risk factors are potentiated …

Cardiovascular diseases are the major cause of morbidity and mortality in renal transplant
recipients. We report our experience in the treatment of patients with renal allograft who …